Serum RASSF1A methylation was more frequently detected in neuroblastoma patients with age ⩾12 months at diagnosis (P=0.002), stage 4 (P<0.001) and MYCN amplification (P<0.001). This evidence concerns the gene MYCN and neuroblastoma.